Plain-English translation of NCT06691399 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether chlorhexidine—a rinse solution used for mouth care—can help prevent pneumonia in people with COPD who are very ill and admitted to an intensive care unit (ICU). The study compares two groups: one receiving standard mouth care twice daily, and another receiving standard mouth care plus the chlorhexidine rinse solution. The goal is to see if this medication can reduce the risk of developing pneumonia while in the hospital.
Critically ill patients in ICUs are at very high risk of developing pneumonia from bacteria that grow in their mouth and are then inhaled into the lungs. Since these patients often can't clean their own mouths due to their illness, researchers want to test whether using this medication as part of daily mouth care can kill harmful bacteria and prevent serious infections.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either standard mouth care or standard mouth care plus the chlorhexidine rinse solution, both given twice daily while you are in the ICU. Your medical team will monitor you to see if you develop pneumonia and will assess your overall oral health. The study involves 60 participants total and focuses on care you'll receive as part of your regular hospital stay.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Egypt